High-Risk Oral Precancerous Disease
1 clinical trials · Condition
◉ Watch High-Risk Oral Precancerous Disease
| Record | Firm | Date |
|---|---|---|
| Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease (NCT06623110) | Glenn J. Hanna | 2025-01-01 |
Track High-Risk Oral Precancerous Disease automatically
Every clearance here is in the API, with alerts when new ones post.